“Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1”, Reumatismo, vol. 63, no. 2, pp. 91–96, Jun. 2011, doi: 10.4081/reumatismo.2011.91.